Latest Form 4 insider transactions

NASDAQ
Thomas C Baker, Sr. VP, CFO & Treasurer of Pc Connection Inc, sold 20,000 shares of common stock on July 31, 2026.
NASDAQ
Su Ping Lu, SrVP, General Counsel, CorpSec of Honeywell International Inc, reported multiple transactions in common stock on July 30, 2026.
NYSE
Hershey Trust Co Trustee In Trust For Milton Hershey School reported changes in beneficial ownership of Hershey Co common stock on July 30, 2026.
NASDAQ
Gregory L Weaver, Chief Financial Officer of Altimmune, Inc., received 1,753 shares of common stock on July 31, 2026.
NASDAQ
M Scot Roberts, Chief Scientific Officer of Altimmune, Inc., received 875 shares of common stock on July 31, 2026.
NASDAQ
Pierre Sargis Sayad, Chief Medical Officer of Fennec Pharmaceuticals Inc., received 168 shares of common stock on July 31, 2026.
NASDAQ
Terry L Evans, Chief Commercial Officer of Fennec Pharmaceuticals Inc., received 168 shares of common stock on July 31, 2026.
NASDAQ
David Richard Johnson, Chief Financial Officer of Drilling Tools International Corp, reported a transaction in 9,181 shares of common stock on February 28, 2026.
NASDAQ
Christiana Marie Cioffi, Chief Strategy Officer of Fennec Pharmaceuticals Inc., received 156 shares of common stock on July 31, 2026.
NASDAQ
Trent Pope, See Remarks of Drilling Tools International Corp, reported a transaction in 4,448 shares of common stock on February 28, 2026.
NASDAQ
Jeffrey S. Hackman, Chief Executive Officer and a Director of Fennec Pharmaceuticals Inc., received 1,159 shares of common stock on July 31, 2026.
Laurie Keating, a Director of Allovir, Inc., received 18,000 shares of common stock on August 1, 2026.
NASDAQ
Aldo Rodriguez, Vice President of Sales of Drilling Tools International Corp, reported a transaction in 7,561 shares of common stock on February 28, 2026.
NASDAQ
Brian Lorig, EVP, KLA Global Services of Kla Corp, reported multiple transactions in common stock on August 1, 2026.
NASDAQ
Bren D. Higgins, EVP & Chief Financial Officer of Kla Corp, reported multiple transactions in common stock on August 1, 2026.
NASDAQ
Mary Beth Wilkinson, EVP, CLO and Secretary of Kla Corp, reported multiple transactions in common stock on August 1, 2026.
NASDAQ
Michael Wayne Domino Jr., President, DTR Division of Drilling Tools International Corp, reported a transaction in 7,495 shares of common stock on February 28, 2026.
NASDAQ
Virendra A Kirloskar, SVP & Chief Accounting Officer of Kla Corp, reported multiple transactions in common stock on August 1, 2026.
NASDAQ
Julie G Castle, a Director of Sierra Bancorp, sold 1,000 shares of common stock on July 31, 2026 for $40.70 per share.
Hrt Financial Lp reported changes in beneficial ownership of NorthView Acquisition Corp common stock on July 28, 2026.
NASDAQ
Yan Liang, See Remarks of GDS Holdings Ltd, reported a transaction in 11,166 shares of common stock on August 3, 2026.
NYSE
Todd N. Scruggs, SVP, CFO of Helmerich & Payne, Inc., reported a transaction in 2,150 shares of common stock on July 31, 2026.
NASDAQ
Sherif Seddik, Chief Revenue Officer of Check Point Software Technologies Ltd, reported a transaction in 801 shares of common stock on July 31, 2026.
NASDAQ
Daniel Antony Newman, Chief financial officer of GDS Holdings Ltd, reported a transaction in 51,374 shares of common stock on August 3, 2026.
NASDAQ
Nadiv Zafrir, CEO and a Director of Check Point Software Technologies Ltd, reported a transaction in 956 shares of common stock on July 31, 2026.
NASDAQ
William Wei Huang, Chairman and CEO and a Director of GDS Holdings Ltd, reported a transaction in 53,334 shares of common stock on August 3, 2026.
NASDAQ
ProLogium and TDAC announced a US$50 million primary capital investment commitment from existing shareholders to support their business combination and accelerate battery production.
NYSE
Richard Adam Norwitt, President & CEO and a Director of Amphenol Corp /De/, sold 686,104 shares of common stock on July 31, 2026.
NASDAQ
Gil Shwed, a Director and 10% owner of Check Point Software Technologies Ltd, reported a transaction in 17 shares of common stock on July 31, 2026.
NASDAQ
Boer Daniel Anton De, Chief Executive Officer and a Director of ProQR Therapeutics N.V., purchased 200,000 shares of common stock on July 31, 2026 for $1.77 per share.